In the current study we demonstrate that the expression of glycosyltransferase GLT8D2 was significantly upregulated in CDDP resistance-ovarian cancer samples and GLT8D2 confers CDDP resistance on ovarian cancer cells both in vitro and in vivo. This evidence concerns the gene GLT8D2 and ovarian cancer.